| PERIOD ENDING | 28-Mar-09 | 27-Dec-08 | 27-Sep-08 | 28-Jun-08 | | Total Revenue | 339,665 | 410,675 | 501,204 | 501,267 | | Cost of Revenue | 171,960 | 211,590 | 209,654 | 200,857 | | | Gross Profit | 167,705 | 199,085 | 291,550 | 300,410 | | | Operating Expenses | | Research Development | 120,974 | 144,283 | 138,915 | 145,047 | | Selling General and Administrative | 35,339 | 74,376 | 47,601 | 60,484 | | Non Recurring | 28,346 | 61,266 | 11,449 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (16,954) | (80,840) | 93,585 | 94,879 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (228) | 7,385 | 9,101 | 5,832 | | Earnings Before Interest And Taxes | (17,182) | (73,455) | 102,686 | 100,711 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (17,182) | (73,455) | 102,686 | 100,711 | | Income Tax Expense | 9,244 | (34,671) | 35,119 | 34,664 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (26,426) | (38,784) | 67,567 | 66,047 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (26,426) | (38,784) | 67,567 | 66,047 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($26,426) | ($38,784) | $67,567 | $66,047 |
|
0.45% Nasdaq 
0.20%
Income Statement
